Sevelamer Carbonate

Common brands: Renvela, Revenla, Lasix, Aspirin 325, Aspirin 81

Top reporter: Genzyme Corporation

Nonsteroidal Anti-inflammatory Drug [EPC]Loop Diuretic [EPC]beta-Adrenergic Blocker [EPC]Corticosteroid [EPC]Dihydropyridine Calcium Channel Blocker [EPC]
11,349
Total Reports
2,369
Serious Reports
1,212
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.68%)

Patient Demographics

Male
3,700
Female
3,388

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Sevelamer Carbonate.

# Reaction Reports % of Total
1 CONSTIPATION 2,541
19.1%
2 DIARRHOEA 1,030
7.8%
3 PRURITUS 1,008
7.6%
4 NAUSEA 813
6.1%
5 CHRONIC KIDNEY DISEASE 676
5.1%
6 END STAGE RENAL DISEASE 671
5.1%
7 RENAL FAILURE 663
5.0%
8 DEATH 622
4.7%
9 VOMITING 526
4.0%
10 ACUTE KIDNEY INJURY 508
3.8%
11 ABDOMINAL PAIN 305
2.3%
12 NEPHROGENIC ANAEMIA 297
2.2%
13 DYSPNOEA 291
2.2%
14 FATIGUE 262
2.0%
15 FLATULENCE 251
1.9%
16 PNEUMONIA 237
1.8%
17 OFF LABEL USE 228
1.7%
18 PAIN 211
1.6%
19 HOSPITALISATION 199
1.5%
20 HYPOTENSION 199
1.5%
21 ASTHENIA 193
1.5%
22 RASH 187
1.4%
23 DYSPEPSIA 181
1.4%
24 HYPERPARATHYROIDISM SECONDARY 181
1.4%
25 DIZZINESS 174
1.3%
26 ANAEMIA 171
1.3%
27 HYPERPHOSPHATAEMIA 169
1.3%
28 MALAISE 169
1.3%
29 RENAL INJURY 167
1.3%
30 DRUG INEFFECTIVE 151
1.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.